Postoperative Outcomes of a Toric AddOn Intraocular Lens After Keratoplasty and Cataract Surgery
Key facts
- Who runs it
- Medical University of Vienna
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 27 Aug 2026
- Expected to end
- Feb 2029
- Type of study
- Observational
- Treatments tested
- AddOn toric IOL implantation
- Record updated
- 4 September 2026
Who can take part
- Age
- 45 years to 95 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Gender: female, male, or diverse
- Ophthalmological diagnosis: pseudophakic patients after keratoplasty
- Age: 45 to 95 years
- Complication-free cataract surgery using phacoemulsification and implantation of a posterior chamber lens
- Complication-free keratoplasty and regular postoperative corneal astigmatism > 1 diopter (D)
- Pupil diameter in mydriasis > 5.5 mm
Who cannot take part
- History of uveitis or iritis
- Uncontrolled systemic or ocular disease
- Uncontrolled glaucoma
- Proliferative diabetic retinopathy
- Iris neovascularization
- Microphthalmus
- Recurrent intraocular inflammation of unknown cause
- Blindness in the other eye
- Pregnancy
- Breastfeeding
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 45 and 95 years old?
This trial is currently available in Austria.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this clinical study is to evaluate a toric add-on intraocular lens (IOL) for the correction of high astigmatism in patients who have undergone keratoplasty and cataract surgery. As this patient group often suffers from significant preoperative residual astigmatism, there is a relevant clinical need for effective and safe refractive treatment options. The implantation of a toric add-on IOL in the ciliary sulcus is intended to significantly reduce postoperative astigmatism and improve visual rehabilitation.
Read full original descriptionShow less
The study is designed as a prospective, monocentric clinical trial with a limited number of cases, as this is a rare condition with limited availability of suitable patients. It is being conducted in accordance with Section 3 of the Austrian Medical Devices Act (MPG 2021) and is investigating a CE-marked add-on intraocular lens implant used within its intended purpose. The postoperative refractive cylinder serves as the primary endpoint, as it reflects the actual effectiveness of astigmatism correction. The rotational stability of the add-on IOL, which significantly influences refractive precision, is recorded as a secondary endpoint.
All study participants will be examined pre- and postoperatively in accordance with applicable medical standards. The results should contribute to the optimization of refractive care after keratoplasty and assess the clinical applicability of toric AddOn IOLs in this specific indication.
Treatments tested
- AddOn toric IOL implantation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Postoperative Outcomes of a Toric Add-On Intraocular Lens After Keratoplasty and Cataract Surgery
- Criteria questions
- Built from NCT07452042, who can take part
- Record updated
- 4 September 2026